A new artificial intelligence-powered tool called MISO (Multi-modal Spatial Omics) can detect cell-level characteristics of cancer by looking at data from extremely small pieces of tissue—some as ...

The proteomic blood test could be a non-invasive tool used to improve detection of the condition, which currently takes an average of 7.5 years to diagnose.

Sapient will be an Alamar certified service provider for Alamar's NULISAseq Inflammation panel and its NULISAseq CNS Disease panel.

Made in collaboration with Korean start-up Nanoentek, this tabletop device uses advanced proteomics (the study of how protein ...

Researchers at Case Western Reserve University School of Medicine have discovered how specific protein regions contribute to breast cancer.

Multi-omics refers to an integrated approach that combines data from multiple "omics" technologies to provide a holistic ...

OncoHost, a global leader in next-generation precision oncology dedicated to advancing personalized cancer therapy, announced today that it has been named a winner in the 2025 BIG Innovation Awards.

Performing multi-omics analyses using a single sample is challenging in toxicology studies. Now, researchers propose a new ...

NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...

SCIEX, a global leader in life science analytical technologies, has enhanced its high-resolution accurate mass spectrometry ...

People living alone have been warned that they could face a higher risk of health complications.According to a study, ...

A new study found that interactions with friends and family may boost our immune system and reduce our risk of diseases such ...